Fallacies in medical practice: Renin-angiotensin-aldosterone system inhibition and COVID-19 as a Paradigm by Filippos Triposkiadis, Konstantinos Dean Boudoulas, Andrew Xanthopoulos, Harisios Boudoulas

Subjects: “…RAAS inhibitors…”
Get full text

Association of RAAS inhibitors on osteoporosis and fracture risk in the hypertensive population–A prospective population-based cohort study in Lanzhou, China by Hongtao Yin, Mengdi Yang, Weiming Sun, Ruixing Zhang, Donghu Zhen, Xulei Tang

Subjects: Get full text

Limited evidence for the usage of renin–angiotensin–aldosterone pathway blockers to prevent arthrofibrosis after total knee arthroplasty. A systematic review of clinical evidence... by Giuseppe Anzillotti, Andreas H. Gomoll, Pietro Conte, Alberto Bulgarelli, Paolo Queirazza, Maurilio Marcacci, Elizaveta Kon, Berardo Di Matteo

Subjects: Get full text

Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population by Joseph B. Muhlestein, Jennifer Kammerer, Tami L. Bair, Kirk U. Knowlton, Viet T. Le, Jeffrey L. Anderson, Donald L. Lappé, Heidi T. May

Subjects: Get full text

Impact of RAAS Inhibitors on Clinical Outcome and Mortality in Patients With STEMI During the COVID-19 Era: A Multicenter Observational Study by Lucia Barbieri, Daniela Trabattoni, Giulio G. Stefanini, Giulio G. Stefanini, Enrico Vizzardi, Gabriele Tumminello, Emilio Assanelli, Marianna Adamo, Carlo A. Pivato, Giovanni Provenzale, Domitilla Gentile, Marco Metra, Stefano Carugo

Subjects: Get full text

A Model to Predict Risk of Hyperkalemia in Patients with Chronic Kidney Disease Using a Large Administrative Claims Database by Sharma A, Alvarez PJ, Woods SD, Dai D

Subjects: Get full text

Covid-19 infection and arterial hypertension: the relationship between the two entities by Svetlana Gavriliuc, Abhinand Sanalkumar, Sneha Jeevan, Ghenadie Calin, Diana Sasu

Subjects: Get full text

Hyperkalemia in heart failure patients: current challenges and future prospects by López-Vilella R, Morillas-Climent H, Plaza-López D, Cebrián-Pinar M, Sánchez-Lázaro I, Almenar-Bonet L

Subjects: “…renin angiotensin aldosterone system (RAAS) inhibitors.…”
Get full text

The effect of renin–angiotensin–aldosterone system inhibitors in patients with hypertension and COVID-19: A meta-analysis of randomized controlled trials and propensity score-match... by Kai Zhang, Lanxin Cao, Nanxia Xuan, Tiancha Huang, Baoping Tian, Wei Cui, Gensheng Zhang, Shufang Zhang

Subjects: Get full text

A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency by Elizabeth M. Sajdel-Sulkowska

Subjects: Get full text

The outcomes of renin-angiotensin-aldosterone system inhibition and immunosuppressive therapy in children with X-linked Alport syndrome by Gülşah Özdemir, Fehime Kara Eroğlu, Belde Kasap Demir, Selçuk Yüksel, Yılmaz Tabel, Ayşe Ağbaş, Ali Düzova, Mutlu Hayran, Fatih Özaltın, Aysun Karabay Bayazıt, Alev Yılmaz, Oğuz Söylemezoğlu, Bora Gülhan, Eda Didem Kurt-Şükür, Emine Atayar, Raziye Atan, İsmail Dursun, Zeynep Birsin Özçakar, Seha Saygılı, Alper Soylu, Rezan Topaloğlu

Subjects: Get full text

Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes by Yihienew M. Bezabih, Alemayehu Bezabih, Endalkachew Alamneh, Gregory M. Peterson, Woldesellassie Bezabhe

Subjects: “…RAAS inhibitors…”
Get full text

Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach by Barbara Bonino, Giovanna Leoncini, Salvatore De Cosmo, Eulalia Greco, Giuseppina T. Russo, Annalisa Giandalia, Francesca Viazzi, Roberto Pontremoli

Subjects: Get full text

Cytokine storm in COVID-19: Potential therapeutics for immunomodulation by Md Mohosin Rana

Subjects: Get full text

Place of renin-angiotensin-aldosterone system inhibitors and statins in the treatment of cardiovascular patients in the context of COVID-19 pandemic by E. V. Sayutina, L. I. Butorova, E. M. Tuaeva, M. A. Osadchuk, M. M. Shamuilova

Subjects: Get full text

Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure by Jean‐Claude Tardif, Jean Rouleau, Glenn M. Chertow, Ayman Al‐Shurbaji, Vera Lisovskaja, Stephanie Gustavson, Yanli Zhao, Nadia Bouabdallaoui, Akshay S. Desai, Alexander Chernyavskiy, Maria Evsina, Béla Merkely, John J.V. McMurray, Marc A. Pfeffer

Subjects: Get full text

COVID‐19 and renin angiotensin aldosterone system: Pathogenesis and therapy by Fatemeh Babajani, Atefeh Kakavand, Hossien Mohammadi, Armin Sharifi, Saba Zakeri, Soheila Asadi, Zeinab Mohseni Afshar, Zohreh Rahimi, Babak Sayad

Subjects: Get full text

RAAS inhibitors are associated with a better chance of surviving of inpatients with Covid-19 without a diagnosis of diabetes mellitus, compared with similar patients who did not re... by Mykola Khalangot, Mykola Khalangot, Nadiia Sheichenko, Vitaly Gurianov, Tamara Zakharchenko, Victor Kravchenko, Mykola Tronko, Mykola Tronko

Subjects: Get full text

Telmisartan in the hypertension treatment: from pharmacological characteristics to clinical benefits by E. V. Sayutina, L. I. Butorova, E. M. Tuaeva, M. A. Osadchuk

Subjects: Get full text

Benefits and harms of sodium‐glucose co‐transporter‐2 inhibitors (SGLT2‐I) and renin–angiotensin–aldosterone system inhibitors (RAAS‐I) versus SGLT2‐Is alone in patients with type... by Samuel Seidu, Setor K Kunutsor, Pinar Topsever, Kamlesh Khunti

Subjects: “…RAAS inhibitor…”
Get full text